Howard Hughes Medical Institute’s Gilead Sciences GILD Stock Holding History

Howard Hughes Medical Institute’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-268	Closed	-$32.9K	–	223
2025 Q4	$32.9K	Buy	268 +1	+0.4%	+$122	0.02%	75
2025 Q3	$29.6K	Sell	267 -2	-0.7%	-$227	0.02%	82
2025 Q2	$29.8K	Buy	+269	New	+$28.6K	0.01%	74
2019 Q2	–	Sell	-50,000	Closed	-$3.25M	–	26
2019 Q1	$3.25M	Hold	50,000	–	–	0.76%	23
2018 Q4	$3.13M	Hold	50,000	–	–	0.99%	25
2018 Q3	$3.86M	Hold	50,000	–	–	1.13%	24
2018 Q2	$3.54M	Hold	50,000	–	–	0.9%	24
2018 Q1	$3.77M	Hold	50,000	–	–	0.98%	23
2017 Q4	$3.58M	Hold	50,000	–	–	0.93%	24
2017 Q3	$4.05M	Hold	50,000	–	–	1.01%	25
2017 Q2	$3.54M	Hold	50,000	–	–	0.65%	37
2017 Q1	$3.4M	Hold	50,000	–	–	0.62%	38
2016 Q4	$3.58M	Hold	50,000	–	–	0.82%	33
2016 Q3	$3.96M	Hold	50,000	–	–	1.02%	27
2016 Q2	$4.17M	Hold	50,000	–	–	1.4%	25
2016 Q1	$4.59M	Hold	50,000	–	–	1.01%	23
2015 Q4	$5.06M	Hold	50,000	–	–	0.77%	19
2015 Q3	$4.91M	Buy	+50,000	New	+$5.55M	0.92%	20

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Howard Hughes Medical Institute's GILD Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 268 shares — an estimated $32.9K sold.

Howard Hughes Medical Institute first reported a position in GILD in Q3 2015 and held it in 18 quarters. The position peaked at $5.06M in Q4 2015. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 268 Gilead Sciences shares in Q1 2026, an estimated $32.9K.
Howard Hughes Medical Institute first reported a position in Gilead Sciences in Q3 2015 and held it in 18 quarters.
Howard Hughes Medical Institute's Gilead Sciences position peaked at $5.06M in Q4 2015.
2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.